Since Profusa was founded in 2009, it has participated in 7 rounds of funding. In total Profusa has raised $80.9M. Profusa's last funding round was on Dec 2025 for a total of $0.
Profusa has 7 investors, including Tasly Pharmaceutical Group, Maxim Integrated Ventures and 3E Bioventures Capital. The latest investment occurred in Dec 2025.